Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma
Ann Surg Oncol
.
2023 Nov;30(12):7688.
doi: 10.1245/s10434-023-14252-2.
Authors
Ashley M Holder
1
,
Jennifer A Wargo
2
,
Merrick I Ross
2
Affiliations
1
Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. amholder@mdanderson.org.
2
Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
PMID:
37661225
DOI:
10.1245/s10434-023-14252-2
No abstract available
Publication types
Published Erratum